# High Flow Therapy (HFT) to Treat Respiratory Insufficiency in Chronic Obstructive Pulmonary Disease (COPD)

> **NCT00990119** · NA · WITHDRAWN · sponsor: **Vapotherm, Inc.**

## Conditions studied

- Pulmonary Disease, Chronic Obstructive
- Respiratory Insufficiency

## Interventions

- **DEVICE:** Vapotherm High Flow Therapy
- **DEVICE:** Non-invasive positive pressure ventilation

## Key facts

- **NCT ID:** NCT00990119
- **Lead sponsor:** Vapotherm, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-09
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Pilot enrollment criteria did not yield intended population.
- **Last updated:** 2020-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00990119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00990119, "High Flow Therapy (HFT) to Treat Respiratory Insufficiency in Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00990119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*